Ubs Group Ag VYNE THERAPEUTICS INC Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024
Number of Shares
14
Previous 25,058 99.94%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
N/A
-25,044 Reduced 99.94%
14 $0
Q2 2024

Aug 13, 2024
BUY
N/A
25,042 Added 156512.5%
25,058 $0
Q1 2024

May 13, 2024
SELL
N/A
-830 Reduced 98.11%
16 $0
Q4 2023

Feb 09, 2024
BUY
N/A
662 Added 359.78%
846 $0
Q3 2023

Nov 09, 2023
SELL
N/A
-902 Reduced 83.06%
184 $0
Q2 2023

Aug 11, 2023
BUY
N/A
721 Added 197.53%
1,086 $0
Q1 2023

May 12, 2023
BUY
N/A
365 New
365 $0
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email